EP2958945
SAMSETT MEÐFERÐ SEM FELUR Í SÉR MÓTEFNI GEGN CLAUDIN 18.2 TIL MEÐFERÐAR Á KRABBAMEINI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.2.2014EP published:
19.10.2022EP application number:
14707647.5
EP translation filed:
3.11.2022Grant published:
15.12.2022EPO information:
European Patent Register
Max expiry date:
17.2.2034Expiry date:
17.2.2027Next due date:
28.2.2027
Title in English:
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCERLanguage of the patent:
English
Timeline
Today
18.2.2014EP application
19.10.2022EP Publication
3.11.2022Translation submitted
15.12.2022Registration published
17.2.2027Expires
Owner
Name:
Astellas Pharma Inc.Address:
5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku Tokyo 103-8411, JP
Name:
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbHAddress:
Freiligrathstrasse 12, 55131 Mainz, DE
Inventor
Name:
SAHIN,UgurAddress:
55116 Mainz, DE
Name:
TÜRECI, ÖzlemAddress:
55116 Mainz, DE
Name:
MITNACHT-KRAUS, RitaAddress:
61169 Friedberg, DE
Name:
WÖLL, StefanAddress:
55299 Nackenheim, DE
Name:
JACOBS, StefanAddress:
55252 Mainz-Kastel, DE
Name:
HEINZ, CorneliaAddress:
55278 Dalheim, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/EP2013/000505Date:
20.2.2013Country:
WO
Classification
Categories:
C07K 16/30, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 31.1.2023
Expires: 17.2.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 31.1.2023
Expires: 17.2.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 6.2.2024
Expires: 17.2.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 11.2.2025
Expires: 17.2.2026
Payer: Árnason Faktor ehf.
Number: 13
Paid: 16.2.2026
Expires: 17.2.2027
Payer: Árnason Faktor ehf.